Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gyu Chul Oh

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
ESC Heart Failure|July 1, 2022
Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fractionGyu Chul Oh, Seokyung An, Hae-Young Lee, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 3, 2021
Nanoparticle-Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial InfarctionSung Pil Kwon, Byung-Hee Hwang, Eun-Hye Park, et al.
Frontiers in Medicine|July 3, 2023
Predictors for early cardiac death after discharge from successfully treated acute myocardial infarctionYoung Choi, Kwan Yong Lee, Sang Hyun Kim, et al.
Journal of Clinical Medicine|February 16, 2020
Management and Prognosis of Heart Failure in Octogenarians: Final Report from the KorAHF RegistryGyu Chul Oh, Hyun-Jai Cho, Sang Eun Lee, et al.
Journal of Clinical Medicine|February 25, 2022
Temporal Trends of Major Bleeding and Its Prediction by the Academic Research Consortium-High Bleeding Risk Criteria in Acute Myocardial InfarctionSungwook Byun, Eun Ho Choo, Gyu-Chul Oh, et al.
BMJ Open|November 6, 2025
High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trialEun Ho Choo, Chan Joon Kim, Byung-Hee Hwang, et al.
The Korean Journal of Internal Medicine|July 22, 2021
The Korean Hypertension Cohort study: design and baseline characteristicsHae-Young Lee, Ju-Yeon Lee, Ho-Gyun Shin, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
Medicine|June 9, 2021
Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymerKyoung-Woo Seo, Hyoung-Mo Yang, Junghan Yoon, et al.
Clinical Hypertension|September 8, 2017
Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trialGyu Chul Oh, Hae-Young Lee, Wook Jin Chung, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
ESC Heart Failure|July 1, 2022
Modified reverse shock index predicts early outcomes of heart failure with reduced ejection fractionGyu Chul Oh, Seokyung An, Hae-Young Lee, et al.
Small (Weinheim an Der Bergstrasse, Germany)|July 3, 2021
Nanoparticle-Mediated Blocking of Excessive Inflammation for Prevention of Heart Failure Following Myocardial InfarctionSung Pil Kwon, Byung-Hee Hwang, Eun-Hye Park, et al.
Frontiers in Medicine|July 3, 2023
Predictors for early cardiac death after discharge from successfully treated acute myocardial infarctionYoung Choi, Kwan Yong Lee, Sang Hyun Kim, et al.
Journal of Clinical Medicine|February 16, 2020
Management and Prognosis of Heart Failure in Octogenarians: Final Report from the KorAHF RegistryGyu Chul Oh, Hyun-Jai Cho, Sang Eun Lee, et al.
Journal of Clinical Medicine|February 25, 2022
Temporal Trends of Major Bleeding and Its Prediction by the Academic Research Consortium-High Bleeding Risk Criteria in Acute Myocardial InfarctionSungwook Byun, Eun Ho Choo, Gyu-Chul Oh, et al.
BMJ Open|November 6, 2025
High-Intensity Statin versus Upfront Equivalent-Dose Combination of Moderate-Intensity Statin with Ezetimibe Following Acute Myocardial Infarction (ROSUZET-AMI): protocol of a multicentre, open-label, randomised non-inferiority trialEun Ho Choo, Chan Joon Kim, Byung-Hee Hwang, et al.
The Korean Journal of Internal Medicine|July 22, 2021
The Korean Hypertension Cohort study: design and baseline characteristicsHae-Young Lee, Ju-Yeon Lee, Ho-Gyun Shin, et al.
Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.
Medicine|June 9, 2021
Five-year clinical outcomes of the first Korean-made sirolimus-eluting coronary stent with abluminal biodegradable polymerKyoung-Woo Seo, Hyoung-Mo Yang, Junghan Yoon, et al.
Clinical Hypertension|September 8, 2017
Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trialGyu Chul Oh, Hae-Young Lee, Wook Jin Chung, et al.
Pageof 5